tility of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes mellitus patients with end-stage renal disease
- Registration Number
- JPRN-UMIN000036647
- Lead Sponsor
- Osafune Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Type 1 diabetes patients Patients having severe infections, before and after operation and trauma Pregnancy Patient who are inadequate to enter this study due to the other reasons by physicians judgments
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Average blood glucose level in Continuous Glucose Monitoring
- Secondary Outcome Measures
Name Time Method HbA1c and GA after CGM